Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Report
  • Published:

Severe interstitial pneumonitis following high-dose cyclophosphamide, thiotepa and docetaxel: two case reports and a review of the literature

Bone Marrow Transplantation volume 27, pages 559–563 (2001)Cite this article

Abstract

The use of high-dose chemotherapy for metastatic breast cancer has been an area of recent interest and the role of such treatment in the management of metastatic breast cancer is still to be defined. Multiple studies have suggested that such treatment can be given with minimal morbidity and mortality. We describe two cases of life-threatening interstitial pneumonitis, following high-dose chemotherapy (HDT) with cyclophosphamide, thiotepa and docetaxel with stem cell rescue given for metastatic breast cancer. The available relevant literature is reviewed. Bone Marrow Transplantation (2001) 27, 559–563.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Ettinger NA, Trulock EP . Pulmonary considerations of organ transplantation Am Rev Respir Dis 1991 144: 213–223

    Article  CAS  Google Scholar 

  2. Cao TM, Negrin RS, Stocker-Goldstein KE et al. Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantation Biol Blood Marrow Transplant 2000 6: 387–394

    Article  CAS  Google Scholar 

  3. Kantrow SP, Hackman RC, Boeckh M et al. Idiopathic pneumonia syndrome: changing spectrum of lung injury after marrow transplantation Transplantation 1997 63: 1079–1086

    Article  CAS  Google Scholar 

  4. Peters W, Rosner G, Vredenburgh J et al. A prospective, randomised comparison of two doses of combination alkylating agents as consolidation after CAF in high-risk primary breast cancer involving ten or more axillary lymph nodes: preliminary results of CALGB 9082/SWOG 9114/NCIC MA-13 Proc Am Soc Clin Oncol 1999 18: 1a (Abstr.)

    Google Scholar 

  5. Prince HM, Rischin D, Toner GC et al. Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study Bone Marrow Transplant 2000 26: 955–961

    Article  CAS  Google Scholar 

  6. Prince HM, Toner GC, Seymour JF et al. Docetaxel effectively mobilizes peripheral blood CD34+ cells Bone Marrow Transplant 2000 26: 483–487

    Article  CAS  Google Scholar 

  7. Cuguilliere A, Berard H, N'Guyen G et al. Cyclophosphamide-induced interstitial pneumopathy. Course data of bronchoalveolar lavage apropos of a case and review of the literature Rev Pneumol Clin 1999 55: 100–104

    CAS  PubMed  Google Scholar 

  8. Merad M, Le Cesne A, Baldeyrou et al. Docetaxel and interstitial pulmonary injury Ann Oncol 1997 8: 191–194

    Article  CAS  Google Scholar 

  9. Lin AY, Flowers CM, Chen MC et al. Interstitial pneumonitis as a late complication of high dose therapy with cyclophosphamide/thiotepa and peripheral blood progenitor cells for carcinoma of the breast Clin Oncol (R Coll Radiol) 1999 10: 65

    Article  Google Scholar 

  10. Mahendra P, Hood IM, Lee MA et al. Interstitial pneumonitis as a late complication of high dose therapy with cyclophosphamide/thiotepa and peripheral blood progenitor cells for carcinoma of the breast Clin Oncol (R Coll Radiol) 1996 8: 198–200

    Article  CAS  Google Scholar 

  11. Holland DK, Dix SP, Geller RB et al. Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa and carboplatin and autologous marrow/stem-cell transplantation and comprehensivesupportive care J Clin Oncol 1996 14: 1156–1164

    Article  CAS  Google Scholar 

  12. Foncuberta MC, Dictor M, Salum G et al. Pulmonary toxicity of high-dose thiotepa containing regimens in breast cancer patients undergoing autologous haematopoietic transplant Blood 1996 88: (Suppl. 1) 3755 (Abstr.)

    Google Scholar 

  13. Prince HM, Millward MJ; Rischin D et al. Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel withperipheral blood progenitor cell and filgrastim support formetastatic and locally advanced breast cancer: results of a phase I study Ann Oncol 1999 10: 479–481

    Article  CAS  Google Scholar 

  14. Adler H, Beland JL, Kozlow W et al. A role for transforming growth factor B1 in the increased pneumonitis in murine allogeneic bone marrow transplant recipients with graft-versus-host disease after pulmonary herpes simplex virus type I infecction Blood 1998 7: 2581–2589

    Google Scholar 

  15. Anscher MS, Peters WP, Reisenbichler H et al. Transforming growth factor B as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer New Engl J Med 1993 328: 1592–1598

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Haematology and Medical Oncology, Blood and Marrow Transplant Service, Peter MacCallum Cancer Institute, Melbourne, Australia

    L Mileshkin, HM Prince, D Rischin & A Zimet

Authors
  1. L Mileshkin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. HM Prince
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D Rischin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A Zimet
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mileshkin, L., Prince, H., Rischin, D. et al. Severe interstitial pneumonitis following high-dose cyclophosphamide, thiotepa and docetaxel: two case reports and a review of the literature. Bone Marrow Transplant 27, 559–563 (2001). https://doi.org/10.1038/sj.bmt.1702803

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702803

Keywords

This article is cited by

Search

Advanced search

Quick links